Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
IgA Nephropathy (IgAN)
51%
Hemodialysis Patients
49%
Intact Parathyroid Hormone (iPTH)
37%
Hemodialysis
35%
End-stage Renal Disease
32%
Secondary Hyperparathyroidism
31%
Maintenance Hemodialysis
26%
Maintenance Hemodialysis Patients
25%
Serum Calcium
24%
Peritoneal Dialysis Patients
24%
Contrast-induced Nephropathy
24%
Confidence Interval
23%
Polymorphism
20%
Iohexol
19%
Serum Phosphorus
19%
Bone Disorders
19%
Overhydration
18%
Chronic Kidney Disease
17%
Proteinuria
17%
Genotype
17%
Risk Factors
16%
Impedance Spectroscopy
16%
Maintenance Dialysis
16%
Kidney Transplant Recipients
16%
Dialysis Patients
16%
Acute Pyelonephritis
16%
Continuous Ambulatory Peritoneal Dialysis
16%
Korean Patients
16%
Cinacalcet
16%
National Cohort Study
16%
Peritonitis
16%
Cyclosporine
16%
Odds Ratio
15%
Phosphorus
15%
CKD-MBD
13%
Tubular Injury
12%
Blood Pressure
12%
Klotho Gene
12%
End-stage Renal Disease Patients
11%
Adverse Events
11%
Dialysis
11%
Renal Biopsy
11%
Cardiovascular Disease
11%
Hazard Ratio
10%
Klotho
10%
Gene Polymorphism
10%
Hemoglobin
10%
Incident Hemodialysis Patients
10%
Biopsy-proven
10%
Acute Renal Failure
10%
Medicine and Dentistry
Hemodialysis
75%
End Stage Renal Disease
49%
Nephropathy
44%
Immunoglobulin A Nephropathy
34%
Isotopes of Calcium
29%
Kidney Function
25%
Vascular Access
25%
Secondary Hyperparathyroidism
25%
Peritoneal Dialysis
24%
Parathyroid Hormone
23%
Hazard Ratio
19%
Disease Exacerbation
17%
Biopsy Technique
17%
Acute Pyelonephritis
16%
Cinacalcet
16%
Arteriovenous Fistula
16%
Immunoglobulin
15%
Chronic Kidney Disease
14%
Blood Pressure
14%
Proteinuria
14%
Bone Disease
13%
Allele
13%
All Cause Mortality
13%
Glomerulonephritis
13%
Infection
12%
Odds Ratio
12%
Glomerular Filtration Rate
12%
Acute Kidney Injury
12%
Renal Biopsy
10%
DNA Polymorphism
10%
Neutrophil
10%
Randomized Controlled Trial
10%
Leukocytosis
10%
Chronic Kidney Disease-Mineral and Bone Disorder
9%
Thrombotic Thrombocytopenic Purpura
9%
Osteoporosis
8%
Cross Sectional Study
8%
Peritonitis
8%
Clinical Significance
8%
Malignant Neoplasm
8%
Pneumomediastinum
8%
Medication Compliance
8%
Cancer Incidence
8%
Pancytopenia
8%
Heart Function
8%
Raoultella planticola
8%
Anaplastic Thyroid Carcinoma
8%
Parathyroidectomy
8%
Pneumothorax
8%
Hexafluronium Bromide
8%
Pharmacology, Toxicology and Pharmaceutical Science
Hemodialysis
100%
Chronic Kidney Failure
40%
End Stage Renal Disease
39%
Immunoglobulin A Nephropathy
32%
Kidney Disease
30%
All Cause Mortality
23%
Creatinine
20%
Parathyroid Hormone
20%
Iohexol
17%
Peritonitis
17%
Cardiovascular Disease
16%
Infection
16%
Acute Pyelonephritis
16%
Fabry Disease
16%
Arteriovenous Fistula
16%
Injury
12%
Inflammation
10%
Atherosclerosis
10%
Hypotension
9%
Bilirubin
9%
Tacrolimus
8%
Adverse Event
8%
Anemia
8%
Secondary Hyperparathyroidism
8%
Mortality Rate
8%
Dipeptidyl Carboxypeptidase Inhibitor
8%
Heinz Body
8%
Adipocytokine
8%
Hemolytic Anemia
8%
Globotriaosylceramide
8%
Immunogenicity
8%
Crohn's Disease
8%
Phase IV
8%
Leukocytosis
8%
Resveratrol
8%
Heme Oxygenase 1
8%
Heart Infarction
8%
Lipoic Acid
8%
Ciclosporin
8%
Cisplatin
8%
Aminosalicylic Acid
8%
Infliximab
8%
Cohort Study
8%
Mycobacterium fortuitum
8%
Alpha-Lipoic Acid
8%
Cinacalcet
8%
Transcription Factor Nrf2
8%
Immunosuppressive Agent
8%
Spine Fracture
8%
Granulocyte Colony Stimulating Factor
8%
